Hisashi Yamanaka
#148,935
Most Influential Person Now
Researcher
Hisashi Yamanaka's AcademicInfluence.com Rankings
Hisashi Yamanakacomputer-science Degrees
Computer Science
#7693
World Rank
#8097
Historical Rank
Computational Linguistics
#1585
World Rank
#1602
Historical Rank
Machine Learning
#2928
World Rank
#2964
Historical Rank
Artificial Intelligence
#3224
World Rank
#3271
Historical Rank
Download Badge
Computer Science
Hisashi Yamanaka's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Hisashi Yamanaka Influential?
(Suggest an Edit or Addition)Hisashi Yamanaka's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Genetics of rheumatoid arthritis contributes to biology and drug discovery (2013) (1877)
- A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. (2004) (403)
- Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis (2007) (368)
- Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values (2006) (368)
- Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population (2012) (299)
- Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis (2014) (279)
- Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses. (2002) (274)
- A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility (2010) (254)
- Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA Study (2010) (248)
- Japanese Guideline for the Management of Hyperuricemia and Gout: Second Edition (2011) (246)
- Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. (2000) (242)
- Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. (2010) (242)
- Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. (2012) (235)
- Serum matrix metalloproteinase 3 as a predictor of the degree of joint destruction during the six months after measurement, in patients with early rheumatoid arthritis. (2000) (217)
- Validation of a Japanese version of the Stanford Health Assessment Questionnaire in 3,763 patients with rheumatoid arthritis. (2003) (180)
- Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients (2011) (167)
- Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population. (2008) (165)
- Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients with Rheumatoid Arthritis in Japan (2014) (161)
- Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan (2009) (159)
- Determinants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activity (2012) (158)
- The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis. (2002) (154)
- Association between PADI4 and rheumatoid arthritis: a replication study. (2005) (152)
- Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis (2013) (152)
- Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose–response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)—a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II (2015) (139)
- Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. (2010) (136)
- Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease. (2014) (131)
- Whole genome association study of rheumatoid arthritis using 27 039 microsatellites. (2005) (131)
- Human Sodium Phosphate Transporter 4 (hNPT4/SLC17A3) as a Common Renal Secretory Pathway for Drugs and Urate* (2010) (130)
- A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis. (2008) (126)
- Two susceptibility loci to Takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population. (2013) (125)
- Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I) (2013) (125)
- Haplotype analysis revealed no association between the PTPN22 gene and RA in a Japanese population. (2006) (124)
- Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH study (2011) (120)
- Inhibition of NF-kappaB signaling by fenofibrate, a peroxisome proliferator-activated receptor-alpha ligand, presents a therapeutic strategy for rheumatoid arthritis. (2005) (116)
- Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study (2016) (114)
- A Genome-Wide Association Study Identified AFF1 as a Susceptibility Locus for Systemic Lupus Eyrthematosus in Japanese (2012) (112)
- Polygenic burdens on cell-specific pathways underlie the risk of rheumatoid arthritis (2017) (112)
- Characterization of human poly(ADP-ribose) polymerase with autoantibodies. (1988) (111)
- Efficacy and safety of tofacitinib as monotherapy in Japanese patients with active rheumatoid arthritis: a 12-week, randomized, phase 2 study (2015) (109)
- Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture. (1987) (108)
- Treat-to-target (T2T) recommendations for gout (2016) (103)
- Clinical manifestations of neurological involvement in primary Sjögren’s syndrome (2011) (101)
- Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study (2013) (100)
- The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population. (2010) (96)
- Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients (2012) (94)
- The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression (2015) (92)
- Validation of the associations between single nucleotide polymorphisms or haplotypes and responses to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a proposal for prospective pharmacogenomic study in clinical practice (2007) (91)
- Frequency of Class III and IV Nephritis in Systemic Lupus Erythematosus Without Clinical Renal Involvement: An Analysis of Predictive Measures (2012) (90)
- Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial (2019) (89)
- Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients (2012) (88)
- Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study) (2016) (88)
- Brief Report: Takayasu Arteritis and Ulcerative Colitis: High Rate of Co‐Occurrence and Genetic Overlap (2015) (88)
- Continuation of Methotrexate Resulted in Better Clinical and Radiographic Outcomes Than Discontinuation upon Starting Etanercept in Patients with Rheumatoid Arthritis: 52-week Results from the JESMR Study (2011) (85)
- What's in season for rheumatoid arthritis patients? Seasonal fluctuations in disease activity. (2007) (84)
- Molecular aspects of rheumatoid arthritis: role of transcription factors (2008) (84)
- Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients—REACTION 52-week study (2011) (83)
- Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan (2006) (83)
- Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study) (2010) (82)
- Clinical Manifestations of Adult‐Onset Still's Disease Presenting With Erosive Arthritis: Association With Low Levels of Ferritin and Interleukin‐18 (2014) (81)
- Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis (2005) (81)
- Outcome measures for acute and chronic gout. (2005) (79)
- Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients. (2011) (77)
- Adverse effects of sulfasalazine in patients with rheumatoid arthritis are associated with diplotype configuration at the N-acetyltransferase 2 gene. (2002) (76)
- Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis (2011) (76)
- Brief report: Association of HLA-DRB1*0101/*0405 with susceptibility to anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis in the Japanese population. (2012) (75)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM) (2007) (75)
- Improvement of disease activity of rheumatoid arthritis patients from 2000 to 2006 in a large observational cohort study IORRA in Japan (2007) (74)
- IL-6, IL-8, and IL-10 Are Associated with Hyperferritinemia in Rapidly Progressive Interstitial Lung Disease with Polymyositis/Dermatomyositis (2014) (73)
- Beneficial action of statins in patients with rheumatoid arthritis in a large observational cohort. (2007) (72)
- Evaluation of the pharmacokinetic equivalence and 54-week efficacy and safety of CT-P13 and innovator infliximab in Japanese patients with rheumatoid arthritis (2015) (72)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2) (2008) (72)
- Molecular targets of rheumatoid arthritis. (2008) (72)
- A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout (2007) (72)
- Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis (2016) (71)
- Management of rheumatoid arthritis: the 2012 perspective (2013) (71)
- Associated factors for falls and fear of falling in Japanese patients with rheumatoid arthritis (2009) (70)
- Potential impact of observational cohort studies in Japan on rheumatoid arthritis research and practice (2006) (69)
- Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjögren’s syndrome (2009) (68)
- Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study. (2011) (67)
- Sodium-dependent phosphate cotransporter type 1 sequence polymorphisms in male patients with gout (2009) (67)
- Incidence of malignancy in Japanese patients with rheumatoid arthritis (2011) (66)
- Effects of Smoking and Shared Epitope on the Production of Anti–Citrullinated Peptide Antibody in a Japanese Adult Population (2014) (66)
- A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout. (2005) (65)
- Programmed cell death and adenine deoxynucleotide metabolism in human lymphocytes. (1988) (65)
- Decrease in orthopaedic operations, including total joint replacements, in patients with rheumatoid arthritis between 2001 and 2007: data from Japanese outpatients in a single institute-based large observational cohort (IORRA) (2009) (65)
- Familial juvenile hyperuricemic nephropathy: detection of mutations in the uromodulin gene in five Japanese families. (2004) (64)
- The Influence of Sex on Patients with Rheumatoid Arthritis in a Large Observational Cohort (2009) (63)
- Contribution of a Non-classical HLA Gene, HLA-DOA, to the Risk of Rheumatoid Arthritis. (2016) (63)
- Cytokines and Chemokines in Neuropsychiatric Syndromes of Systemic Lupus Erythematosus (2010) (62)
- Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study (2017) (62)
- Efficient management of rheumatoid arthritis significantly reduces long-term functional disability (2007) (61)
- Localization of a gene for familial juvenile hyperuricemic nephropathy causing underexcretion-type gout to 16p12 by genome-wide linkage analysis of a large family. (2000) (61)
- Safety and efficacy of CT-P13 in Japanese patients with rheumatoid arthritis in an extension phase or after switching from infliximab (2017) (60)
- Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus. (2011) (60)
- Efficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: the J-RAPID randomized, placebo-controlled trial (2014) (60)
- Human autoantibodies to poly(adenosine diphosphate-ribose) polymerase. (1987) (59)
- The association of fatigue, comorbidity burden, disease activity, disability and gross domestic product in patients with rheumatoid arthritis. Results from 34 countries participating in the Quest-RA program. (2014) (59)
- Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis (2011) (59)
- Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus (2006) (58)
- Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks (2012) (57)
- Recent Treatment of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies (2015) (56)
- Therapeutic effects of the combination of methotrexate and bucillamine in early rheumatoid arthritis: a multicenter, double-blind, randomized controlled study (2005) (56)
- Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease. (2010) (56)
- PLD4 as a novel susceptibility gene for systemic sclerosis in a Japanese population. (2013) (55)
- An Allopurinol-Controlled, Randomized, Double-Dummy, Double-Blind, Parallel Between-Group, Comparative Study of Febuxostat (TMX-67), a Non-Purine-Selective Inhibitor of Xanthine Oxidase, in Patients With Hyperuricemia Including Those With Gout in Japan: Phase 3 Clinical Study (2011) (54)
- Expression and function of the co-stimulator H4/ICOS on activated T cells of patients with rheumatoid arthritis. (2003) (53)
- Functional Variants in NFKBIE and RTKN2 Involved in Activation of the NF-κB Pathway Are Associated with Rheumatoid Arthritis in Japanese (2012) (53)
- Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises (2016) (53)
- IL-23 and Th17 Disease in Inflammatory Arthritis (2017) (52)
- Gout and hyperuricemia in young people (2011) (52)
- Interstitial Lung Disease with ANCA-associated Vasculitis (2015) (52)
- Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial (2016) (51)
- Efficacy and safety of certolizumab pegol without methotrexate co-administration in Japanese patients with active rheumatoid arthritis: The HIKARI randomized, placebo-controlled trial (2014) (51)
- Impact of shoulder, elbow, and knee joint involvement on assessment of rheumatoid arthritis using the American College of Rheumatology Core Data Set. (2005) (50)
- Association between GLUT9 and gout in Japanese men (2010) (50)
- Severe impairment in adenine metabolism with a partial deficiency of adenine phosphoribosyltransferase. (1985) (50)
- Inhibition of NF-kappaB signaling by fasudil as a potential therapeutic strategy for rheumatoid arthritis. (2010) (50)
- TNF as a Target of Inflammation in Rheumatoid Arthritis. (2015) (49)
- Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout (2019) (49)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J) (2008) (48)
- RANKL: A therapeutic target for bone destruction in rheumatoid arthritis (2018) (47)
- Influence of methotrexate dose on its efficacy and safety in rheumatoid arthritis patients: evidence based on the variety of prescribing approaches among practicing Japanese rheumatologists in a single institute-based large observational cohort (IORRA) (2007) (46)
- A large observational cohort study of rheumatoid arthritis, IORRA: Providing context for today’s treatment options (2020) (46)
- Disability and patient’s appraisal of general health contribute to depressed mood in rheumatoid arthritis in a large clinical study in Japan (2006) (46)
- Elevation of serum matrix metalloproteinase-3 as a predictive marker for the long-term disability of rheumatoid arthritis patients in a prospective observational cohort IORRA (2007) (45)
- Risk factors associated with incident clinical vertebral and nonvertebral fractures in Japanese women with rheumatoid arthritis: a prospective 54-month observational study. (2007) (45)
- Essence of the revised guideline for the management of hyperuricemia and gout. (2012) (45)
- Biologic-free remission of established rheumatoid arthritis after discontinuation of abatacept: a prospective, multicentre, observational study in Japan (2014) (45)
- Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis: retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study) (2011) (44)
- Association study of a polymorphism of the CTGF gene and susceptibility to systemic sclerosis in the Japanese population (2008) (44)
- Identification of Three New Autoantibodies Associated with Systemic Lupus Erythematosus Using Two Proteomic Approaches (2011) (43)
- A large-scale association study identified multiple HLA-DRB1 alleles associated with ACPA-negative rheumatoid arthritis in Japanese subjects (2011) (42)
- PADI4 and HLA-DRB1 Are Genetic Risks for Radiographic Progression in RA Patients, Independent of ACPA Status: Results from the IORRA Cohort Study (2013) (41)
- Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective randomised controlled study (the second year of the SURPRISE study) (2018) (40)
- Association of Takayasu arteritis with HLA-B 67:01 and two amino acids in HLA-B protein. (2013) (40)
- Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese (2009) (40)
- Hyperferritinaemia and macrophage activation in a patient with interstitial lung disease with clinically amyopathic DM. (2012) (39)
- Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity (2012) (38)
- Incidence of serious respiratory infections in patients with rheumatoid arthritis treated with tocilizumab (2012) (38)
- Prevalence of and factors associated with vitamin D deficiency in 4,793 Japanese patients with rheumatoid arthritis (2013) (38)
- Recent Trends in Orthopedic Surgery Aiming to Improve Quality of Life for Those with Rheumatoid Arthritis: Data from a Large Observational Cohort (2014) (37)
- Ten-year incidences of self-reported non-vertebral fractures in Japanese patients with rheumatoid arthritis: discrepancy between disease activity control and the incidence of non-vertebral fracture (2015) (37)
- Failure to confirm association between PDCD1 polymorphisms and rheumatoid arthritis in a Japanese population (2007) (36)
- Presence of comorbidity affects both treatment strategies and outcomes in disease activity, physical function, and quality of life in patients with rheumatoid arthritis (2015) (36)
- [Pharmacogenetics of disease modifying anti-rheumatic drugs]. (2002) (36)
- Risk factors associated with the occurrence of hip fracture in Japanese patients with rheumatoid arthritis: a prospective observational cohort study (2013) (35)
- Effect of Genetic Polymorphisms on Development of Gout (2013) (35)
- Pharmacokinetics and Pharmacodynamics of Febuxostat (TMX‐67), a Non‐Purine Selective Inhibitor of Xanthine Oxidase/Xanthine Dehydrogenase (NPSIXO) in Patients with Gout and/or Hyperuricemia (2004) (35)
- Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung disease. (2012) (35)
- Positive association between STAT4 polymorphisms and polymyositis/dermatomyositis in a Japanese population (2012) (35)
- Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study (2010) (34)
- ACPA-Negative RA Consists of Two Genetically Distinct Subsets Based on RF Positivity in Japanese (2012) (34)
- Vaccination against seasonal influenza is effective in Japanese patients with rheumatoid arthritis enrolled in a large observational cohort (2013) (34)
- Recovery of clinical but not radiographic outcomes by the delayed addition of adalimumab to methotrexate-treated Japanese patients with early rheumatoid arthritis: 52-week results of the HOPEFUL-1 trial (2014) (34)
- ErratumCorrection to: Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I) (2014) (33)
- A role for TARC/CCL17, a CC chemokine, in systemic lupus erythematosus. (2003) (33)
- MHC2TA is associated with rheumatoid arthritis in Japanese patients (2006) (33)
- High Frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis (2012) (33)
- Incidence of falls and fear of falling in Japanese patients with rheumatoid arthritis (2011) (32)
- Integration of genetics and miRNA–target gene network identified disease biology implicated in tissue specificity (2018) (32)
- Efficacy of total joint arthroplasty in patients with established rheumatoid arthritis: improved longitudinal effects on disease activity but not on health-related quality of life (2011) (32)
- Single nucleotide polymorphisms in the gene encoding the major histocompatibility complex class II transactivator (CIITA) in systemic lupus erythematosus (2005) (31)
- A twin study of rheumatoid arthritis in the Japanese population (2016) (31)
- Human osteoclastogenic T cells and human osteoclastology. (2009) (31)
- Stimulation of cyclic nucleotide phosphodiesterases from rat brain by activator protein, proteolytic enzymes and a vitamin E derivative. (1977) (31)
- One third of Japanese patients with rheumatoid arthritis use complementary and alternative medicine (2006) (31)
- Declining use of synovectomy surgery for patients with rheumatoid arthritis in Japan (2009) (30)
- Effect of total knee arthroplasty on disease activity in patients with established rheumatoid arthritis: 3-year follow-up results of combined medical therapy and surgical intervention (2010) (30)
- Rheumatoid Factor Is Associated With the Distribution of Hand Joint Destruction in Rheumatoid Arthritis (2015) (29)
- Anti-cyclic citrullinated peptide antibody predicts functional disability in patients with rheumatoid arthritis in a large prospective observational cohort in Japan (2012) (29)
- Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor (2019) (29)
- A Delphi Exercise to Identify Characteristic Features of Gout — Opinions from Patients and Physicians, the First Stage in Developing New Classification Criteria (2013) (28)
- Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis (2015) (28)
- Discontinuation of etanercept after achievement of sustained remission in patients with rheumatoid arthritis who initially had moderate disease activity—results from the ENCOURAGE study, a prospective, international, multicenter randomized study (2016) (28)
- Analysis of direct medical and nonmedical costs for care of rheumatoid arthritis patients using the large cohort database, IORRA (2013) (28)
- Activation of the activin A-ALK-Smad pathway in systemic sclerosis. (2011) (28)
- Risk factors associated with incident fractures in Japanese men with rheumatoid arthritis: a prospective observational cohort study (2008) (28)
- Hypouricaemic effects of yoghurt containing Lactobacillus gasseri PA-3 in patients with hyperuricaemia and/or gout: A randomised, double-blind, placebo-controlled study (2019) (27)
- Real-world treatment of gout and asymptomatic hyperuricemia: A cross-sectional study of Japanese health insurance claims data (2020) (27)
- Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA (2010) (27)
- Diagnosis of heterozygous states for adenine phosphoribosyltransferase deficiency based on detection of in vivo somatic mutants in blood T cells: application to screening of heterozygotes. (1991) (27)
- Efficacy and safety of intravenous cyclophosphamide pulse therapy with oral prednisolone in the treatment of interstitial lung disease with systemic sclerosis: 4-year follow-up (2011) (26)
- Clinical benefit of 1-year certolizumab pegol (CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritis was observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial (2017) (26)
- Risk factors for established vertebral fractures in Japanese patients with rheumatoid arthritis: Results from a large prospective observational cohort study (2015) (26)
- Human autoantibodies to poly(adenosine diphosphate-ribose) polymerase recognize cross-reactive epitopes associated with the catalytic site of the enzyme. (1989) (26)
- Epidemiological characteristics of rheumatoid arthritis in Japan: Prevalence estimates using a nationwide population-based questionnaire survey (2019) (26)
- Postoperative complications in patients with rheumatoid arthritis using a biological agent – A systematic review and meta-analysis (2015) (26)
- Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study (2016) (26)
- Comparison of the second and third generation anti-cyclic citrullinated peptide antibody assays in the diagnosis of Japanese patients with rheumatoid arthritis (2011) (26)
- Effect of matrix metalloproteinase-3 functional SNP on serum matrix metalloproteinase-3 level and outcome measures in Japanese RA patients. (2008) (26)
- Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study (2017) (26)
- Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme (2017) (25)
- Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study. (2011) (25)
- Associations between methotrexate treatment and methylenetetrahydrofolate reductase gene polymorphisms with incident fractures in Japanese female rheumatoid arthritis patients (2009) (25)
- Fracture risk assessment and osteoporosis treatment disparities in 3,970 Japanese patients with rheumatoid arthritis (2011) (25)
- Single nucleotide polymorphisms of CD244 gene predispose to renal and neuropsychiatric manifestations with systemic lupus erythematosus (2010) (24)
- Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database (2011) (24)
- Prevalence of Helicobacter pylori infection and risk of upper gastrointestinal ulcer in patients with rheumatoid arthritis in Japan (2005) (24)
- Elevated Ratio of Th17 Cell-Derived Th1 Cells (CD161+Th1 Cells) to CD161+Th17 Cells in Peripheral Blood of Early-Onset Rheumatoid Arthritis Patients (2016) (24)
- Multicenter, Open-Label Study of Long-Term Administration of Febuxostat (TMX-67) in Japanese Patients With Hyperuricemia Including Gout (2011) (24)
- Brief Report: Main Contribution of DRB1*04:05 Among the Shared Epitope Alleles and Involvement of DRB1 Amino Acid Position 57 in Association With Joint Destruction in Anti–Citrullinated Protein Antibody–Positive Rheumatoid Arthritis (2015) (24)
- Interferon-induced helicase (IFIH1) polymorphism with systemic lupus erythematosus and dermatomyositis/polymyositis (2010) (24)
- Anti-citrullinated peptide/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a meta-analysis of genome-wide association study in a Japanese population (2015) (24)
- Risk factors for total knee arthroplasty in rheumatoid arthritis (2007) (24)
- Medical care costs of patients with rheumatoid arthritis during the prebiologics period in Japan: a large prospective observational cohort study (2010) (24)
- Incidence of herpes zoster in Japanese patients with rheumatoid arthritis from 2005 to 2010 (2015) (23)
- NR2-reactive antibody decreases cell viability through augmentation of Ca(2+) influx in systemic lupus erythematosus. (2011) (23)
- Features of patients with rheumatoid arthritis whose debut joint is a foot or ankle joint: A 5,479-case study from the IORRA cohort (2018) (23)
- Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39 (2019) (22)
- [Alcohol ingestion and hyperuricemia]. (1996) (22)
- Common characteristics of mutant adenine phosphoribosyltransferases from four separate Japanese families with 2,8-dihydroxyadenine urolithiasis associated with partial enzyme deficiencies (2004) (22)
- Reliability of the SF-36 in Japanese patients with systemic lupus erythematosus and its associations with disease activity and damage: a two-consecutive year prospective study (2018) (22)
- Genome-Wide Association Study and Gene Expression Analysis Identifies CD 84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis (2013) (21)
- Productivity loss of Japanese patients with rheumatoid arthritis – A cross-sectional survey (2018) (21)
- Cartilage oligomeric matrix protein in serum and synovial fluid of rheumatoid arthritis: potential use as a marker for joint cartilage damage (2004) (21)
- A new method for the detection of Lesch-Nyhan heterozygotes by peripheral blood T cell culture using T cell growth factor. (1984) (20)
- Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study. (2011) (20)
- Sites, frequencies, and causes of self-reported fractures in 9,720 rheumatoid arthritis patients: a large prospective observational cohort study in Japan (2013) (20)
- Autosomal dominant transmission of gouty arthritis with renal disease in a large Japanese family. (1991) (20)
- Neurocognitive Impairment in Corticosteroid-naive Patients with Active Systemic Lupus Erythematosus: A Prospective Study (2015) (20)
- Dihydroxyadenine urolithiasis in children with partial deficiency of adenine phosphoribosyltransferase. (1981) (20)
- Association-heterogeneity mapping identifies an Asian-specific association of the GTF2I locus with rheumatoid arthritis (2016) (20)
- Multiple extensor tendon ruptures caused by tophaceous gout (2010) (20)
- Screening for adenine and hypoxanthine phosphoribosyltransferase deficiencies in human erythrocytes by high-performance liquid chromatography. (1987) (20)
- Spinal tophaceous gout mimicking a spinal tumor. (2004) (19)
- T-cell leukemia translocation-associated gene (TCTA) protein is required for human osteoclastogenesis. (2009) (19)
- CTLA-4 CT60 polymorphism is not an independent genetic risk marker of rheumatoid arthritis in a Japanese population (2007) (19)
- Quantitative effect of HLA-DRB1 alleles to ACPA levels in Japanese rheumatoid arthritis: no strong genetic impact of shared epitope to ACPA levels after stratification of HLA-DRB1*09:01 (2012) (19)
- Risk factors associated with the occurrence of distal radius fractures in Japanese patients with rheumatoid arthritis: a prospective observational cohort study (2014) (18)
- Performance of hands and feet radiographs in differentiation of psoriatic arthritis from rheumatoid arthritis (2012) (18)
- Detection of IFN-γ+IL-17+ cells in salivary glands of patients with Sjögren's syndrome and Mikulicz's disease: Potential role of Th17•Th1 in the pathogenesis of autoimmune diseases. (2016) (18)
- Efficacy profile of bucillamine in rheumatoid arthritis patients in a large observational cohort study, IORRA (2006) (18)
- Synovial histology in three Behçet's disease patients with orthopedic surgery. (2002) (18)
- No increased mortality in patients with rheumatoid arthritis treated with biologics: results from the biologics register of six rheumatology institutes in Japan (2013) (18)
- Acceptability and usefulness of mizoribine in the management of rheumatoid arthritis in methotrexate-refractory patients and elderly patients, based on analysis of data from a large-scale observational cohort study (2006) (18)
- Discoveries in the pathophysiology of neuropsychiatric lupus erythematosus: consequences for therapy (2013) (18)
- Low disease activity state with corticosteroid may not represent 'true' low disease activity state in patients with rheumatoid arthritis. (2007) (18)
- Urinary free light chain is a potential biomarker for ISN/RPS class III/IV lupus nephritis. (2013) (18)
- Effect of interleukin-6 receptor inhibitor, tocilizumab, in preventing joint destruction in patients with rheumatoid arthritis showing inadequate response to TNF inhibitors (2014) (18)
- Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance (2018) (18)
- An Association Between Amino Acid Position 74 of HLA–DRB1 and Anti–Citrullinated Protein Antibody Levels in Japanese Patients With Anti–Citrullinated Protein Antibody–Positive Rheumatoid Arthritis (2015) (18)
- A polymorphism in the gene encoding the Fcγ IIIA receptor is a possible genetic marker to predict the primary response to infliximab in Japanese patients with rheumatoid arthritis (2008) (17)
- Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation. (2012) (17)
- Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA database (2016) (17)
- Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritis (2011) (17)
- Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease (2016) (17)
- Comorbidities in Patients with Gout (2011) (17)
- Progressive appearance of overlap syndrome together with autoantibodies in a patient with fatal thrombotic microangiopathy. (2000) (17)
- OP0040 Adding Tocilizumab or Switching to Tocilizumab Monotherapy in RA Patients with Inadequate Response to Methotrexate: 24-Week Results from a Randomized Controlled Study (Surprise Study) (2013) (17)
- Clinical efficacy, radiographic progression, and safety through 156 weeks of therapy with subcutaneous golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis despite prior methotrexate therapy: final results of the randomized GO-FORTH trial (2015) (17)
- Relationship between phosphorylation and cytotoxicity of 2-chloroadenosine and 6-methylmercaptopurine riboside in human cells. (1984) (17)
- Synergistic inhibition of polyamine synthesis and growth by difluoromethylornithine plus methylthioadenosine in methylthioadenosine phosphorylase-deficient murine lymphoma cells. (1987) (17)
- Construct validity, reliability, response rate, and association with disease activity of the quick disabilities of the arm, shoulder and hand questionnaire in the assessment of rheumatoid arthritis (2015) (16)
- A germline mutation abolishing the original stop codon of the human adenine phosphoribosyltransferase (APRT) gene leads to complete loss of the enzyme protein (1998) (16)
- Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort (2017) (16)
- Comparison of characteristics and therapeutic efficacy in rheumatoid arthritis patients treated by rheumatologists and those treated by orthopedic surgeons under a team medicine approach at the same institute (2012) (16)
- Semiquantitative measurement of aquaporin-4 antibodies as a possible surrogate marker of neuromyelitis optica spectrum disorders with systemic autoimmune diseases (2012) (16)
- How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries. (2016) (16)
- Increased HGF and c-Met in muscle tissues of polymyositis and dermatomyositis patients: beneficial roles of HGF in muscle regeneration. (2010) (16)
- Longer operative time is the risk for delayed wound healing after forefoot surgery in patients with rheumatoid arthritis (2016) (16)
- Failure to confirm association between SLC22A4 polymorphism and rheumatoid arthritis in a Japanese population. (2005) (15)
- Arterial Calcification Due to Deficiency of CD73 (ACDC) As One of Rheumatic Diseases Associated With Periarticular Calcification. (2015) (15)
- Cost-effectiveness of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, versus methotrexate in patients with rheumatoid arthritis using real-world data from the IORRA observational cohort study (2015) (15)
- The Influence of Individual Joint Impairment on Functional Disability in Rheumatoid Arthritis Using a Large Observational Database of Japanese Patients (2012) (15)
- Allopurinol metabolism in a patient with xanthine oxidase deficiency. (1983) (15)
- New-onset psychiatric disorders after corticosteroid therapy in systemic lupus erythematosus: an observational case-series study (2014) (15)
- KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis/dermatomyositis, but is not a short-term disease-activity biomarker (2019) (15)
- The origin of the most common mutation of adenine phosphoribosyltransferase among Japanese goes back to a prehistoric era (1996) (15)
- Selection against blood cells deficient in hypoxanthine phosphoribosyltransferase (HPRT) in Lesch-Nyhan heterozygotes occurs at the level of multipotent stem cells (1995) (15)
- Efficacy and safety of abatacept in routine care of patients with rheumatoid arthritis: Orencia® as Biological Intensive Treatment for RA (ORBIT) study (2014) (15)
- Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries (2015) (15)
- Association between a C8orf13–BLK Polymorphism and Polymyositis/Dermatomyositis in the Japanese Population: An Additive Effect with STAT4 on Disease Susceptibility (2014) (15)
- [DMARDs (disease-modifying antirheumatic drugs)]. (2013) (14)
- A GC polymorphism associated with serum 25-hydroxyvitamin D level is a risk factor for hip fracture in Japanese patients with rheumatoid arthritis: 10-year follow-up of the Institute of Rheumatology, Rheumatoid Arthritis cohort study (2014) (14)
- Genetic Susceptibility to Interstitial Lung Disease Associated with Systemic Sclerosis (2015) (14)
- Serum uric acid control for prevention of gout flare in patients with asymptomatic hyperuricaemia: a retrospective cohort study of health insurance claims and medical check-up data in Japan (2021) (14)
- Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus (2019) (14)
- Efficacy of denosumab with regard to bone destruction in prognostic subgroups of Japanese rheumatoid arthritis patients from the phase II DRIVE study (2019) (14)
- Dental treatments, tooth extractions, and osteonecrosis of the jaw in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study (2017) (14)
- Low disease activity for up to 3 years after adalimumab discontinuation in patients with early rheumatoid arthritis: 2-year results of the HOPEFUL-3 Study (2017) (14)
- A1330V polymorphism of low-density lipoprotein receptor-related protein 5 gene and self-reported incident fractures in Japanese female patients with rheumatoid arthritis (2009) (14)
- No increased risk of herpes zoster in TNF inhibitor and non‐TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database (2018) (14)
- Japanese Guideline for the management of hyperuricemia and gout (2nd edition) (2013) (14)
- Poly(ADP-ribose) polymerase inhibits DNA synthesis initiation in the absence of NAD. (1989) (13)
- Ghrelin attenuates collagen production in lesional fibroblasts from patients with systemic sclerosis. (2013) (13)
- Functional disability can deteriorate despite suppression of disease activity in patients with rheumatoid arthritis: a large observational cohort study (2013) (13)
- The intra-articular efficacy of hyaluronate injections in the treatment of rheumatoid arthritis (2009) (13)
- Disability is the major negative predictor for achievement of Boolean-based remission in patients with rheumatoid arthritis treated with tocilizumab (2013) (13)
- Major depressive disorder in patients with rheumatoid arthritis (2013) (13)
- Risk factors associated with the occurrence of proximal humerus fractures in patients with rheumatoid arthritis: a custom strategy for preventing proximal humerus fractures (2016) (13)
- Geranylgeranylacetone, a non-toxic inducer of heat shock protein, induces cell death in fibroblast-like synoviocytes from patients with rheumatoid arthritis (2009) (13)
- Adenine phosphoribosyltransferase deficiency identified by urinary sediment analysis: cellular and molecular confirmation (1995) (13)
- Sildenafil attenuates the fibrotic phenotype of skin fibroblasts in patients with systemic sclerosis. (2015) (13)
- Safety and Effectiveness of 6 Months’ Etanercept Monotherapy and Combination Therapy in Japanese Patients with Rheumatoid Arthritis: Effect of Concomitant Disease-modifying Antirheumatic Drugs (2013) (13)
- Early response to certolizumab pegol predicts long-term outcomes in patients with active rheumatoid arthritis: results from the Japanese studies (2015) (13)
- Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients (2018) (13)
- Efficacy and safety of tofacitinib for the treatment of rheumatoid arthritis in patients from the Asia‐Pacific region: Post‐hoc analyses of pooled clinical study data (2019) (12)
- SAT0100 Abatacept Biologic-Free Remission Study in Established Rheumatoid Arthritis Patients orion Study (2013) (12)
- Efficacy of adjunct tacrolimus treatment in patients with rheumatoid arthritis with inadequate responses to methotrexate (2013) (12)
- RANK Expression and Osteoclastogenesis in Human Monocytes in Peripheral Blood from Rheumatoid Arthritis Patients (2016) (12)
- Obstacles to the implementation of the treat-to-target strategy for rheumatoid arthritis in clinical practice in Japan (2015) (12)
- Effects of febuxostat on serum urate level in Japanese hyperuricemia patients (2015) (12)
- Efficacy and safety of tacrolimus in 101 consecutive patients with rheumatoid arthritis (2010) (12)
- Reduction of methotrexate and glucocorticoids use after the introduction of biological disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis in daily practice based on the IORRA cohort (2018) (12)
- Chondrocyte of rheumatoid arthritis serve as a source of intra-articular acute-phase serum amyloid A protein. (2008) (12)
- Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012 (2015) (12)
- Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: 52-week results from an open-label extension of the J-RAPID study (2014) (11)
- Association of Serum Soluble CD163 with Polymyositis and Dermatomyositis, Especially in Anti-MDA5 Antibody–positive Cases (2018) (11)
- Functional analysis of human sodium-phosphate transporter 4 (NPT4/SLC17A3) polymorphisms. (2011) (11)
- IL-35 inhibits human osteoclastogenesis from monocytes induced by receptor-activator of NF-κB ligand (2018) (11)
- Factors associated with achieving target serum uric acid level and occurrence of gouty arthritis: A retrospective observational study of Japanese health insurance claims data (2020) (11)
- Risk of opportunistic infections in patients with antineutrophil cytoplasmic antibody‐associated vasculitis, using a Japanese health insurance database (2019) (11)
- Standard treatment in daily clinical practice for early rheumatoid arthritis improved disease activity from 2001 to 2006 (2011) (11)
- Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis: results from a large Japanese postmarketing surveillance study (2011) (11)
- Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients who could not receive methotrexate: 52-week results from an open-label extension of the HIKARI study (2014) (11)
- Comparison of the Rau method and the Larsen method in the evaluation of radiographic progression in early rheumatoid arthritis. (2002) (10)
- An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study. (2011) (10)
- Methemoglobinemia induced by trimethoprim-sulfamethoxazole in a patient with systemic lupus erythematosus. (2013) (10)
- Validation of the Japanese version of the Systemic Lupus Activity Questionnaire that includes physician-based assessments in a large observational cohort (2016) (10)
- Effect of Tocilizumab on growth impairment in systemic juvenile idiopathic arthritis with long-term corticosteroid therapy (2014) (10)
- Time-averaged disease activity fits better joint destruction in rheumatoid arthritis (2017) (10)
- Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in Japan (2017) (10)
- Psychological distress in corticosteroid-naive patients with systemic lupus erythematosus: A prospective cross-sectional study (2016) (10)
- Erratum: Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM) (Modern Rheumatology (2007) vol. 17 (28-32) 10.1007/s10165-006-0532-0) (2007) (9)
- Profound toxicity of deoxyadenosine and 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. (1989) (9)
- Phosphoribosylpyrophosphate synthetase in human erythrocytes: assay and kinetic studies using high-performance liquid chromatography. (1991) (9)
- The process of collecting and evaluating evidences for the development of Guidelines for the management of rheumatoid arthritis, Japan College of Rheumatology 2014: Utilization of GRADE approach (2016) (9)
- [Leflunomide: clinical effectiveness and mechanism of action]. (2003) (9)
- An asymptomatic germline missense base substitution in the hypoxanthine phosphoribosyltransferase (HPRT) gene that reduces the amount of enzyme in humans (1996) (9)
- Drug Treatment Algorithm and Recommendations from the 2020 update of the Japan College of Rheumatology Clinical Practice Guidelines for the Management of Rheumatoid Arthritis-Secondary Publication. (2022) (9)
- Interleukin-18 promoter polymorphisms in Japanese patients with rheumatoid arthritis: protective effect of the T allele and T/T genotype at rs360722 (2011) (9)
- Return of infliximab efficacy after total knee arthroplasty in a patient with rheumatoid arthritis (2008) (9)
- Efficacy and safety of tofacitinib in Japanese patients with rheumatoid arthritis by background methotrexate dose: A post hoc analysis of clinical trial data (2019) (9)
- Post-hoc analysis showing better clinical response with the loading dose of certolizumab pegol in Japanese patients with active rheumatoid arthritis (2015) (9)
- An Osteoprotegerin Gene Polymorphism Is Associated with an Increased Risk of Hip Fracture in Japanese Patients with Rheumatoid Arthritis: Results from the IORRA Observational Cohort Study (2014) (8)
- Opinions of Japanese rheumatology physicians regarding clinical practice guidelines. (2010) (8)
- Serum antibodies against the 70k polypeptides of the U1 ribonucleoprotein complex are associated with psychiatric syndromes in systemic lupus erythematosus: a retrospective study (2013) (8)
- A Comparative Study to Assess the Efficacy, Safety, and Immunogenicity of YLB113 and the Etanercept Reference Product for the Treatment of Patients with Rheumatoid Arthritis (2019) (8)
- Risk factors for wrist surgery in rheumatoid arthritis (2008) (8)
- Association of a polymorphism in the monocyte chemoattractant protein-1/CCL2 gene and lupus nephritis in systemic lupus erythematosus patients. (2008) (8)
- Effects of long-term corticosteroid usage on functional disability in patients with early rheumatoid arthritis, regardless of controlled disease activity (2012) (8)
- Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction (2020) (8)
- Predictors of new bone erosion in rheumatoid arthritis patients receiving conventional synthetic disease-modifying antirheumatic drugs: Analysis of data from the DRIVE and DESIRABLE studies (2019) (8)
- Radiographic repair in three Japanese patients with rheumatoid arthritis treated with bucillamine (2009) (8)
- Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis (2017) (8)
- Nonsteroidal anti-inflammatory drug use does not affect short-term endoscopic and histologic outcomes after Helicobacter pylori eradication in patients with rheumatoid arthritis (2007) (8)
- Association between low-dose pulsed intravenous cyclophosphamide therapy and amenorrhea in patients with systemic lupus erythematosus: A case-control study (2011) (8)
- Lack of association between PADI4 and functional severity in Japanese rheumatoid arthritis patients (2007) (8)
- Reparative radiological changes of a large joint after adalimumab for rheumatoid arthritis (2011) (8)
- Selective expression of MHC class I in the affected muscle of a patient with idiopathic inflammatory myopathy (2009) (7)
- Effectiveness and safety of initiating adalimumab plus ≥12 mg/week methotrexate with adjustable dosing in biologic-naïve patients with early rheumatoid arthritis: HAWK study postmarketing surveillance in Japan (2018) (7)
- Modulation of diphthamide synthesis by 5'-deoxy-5'-methylthioadenosine in murine lymphoma cells. (1986) (7)
- HLA-DRB1 Analysis Identified a Genetically Unique Subset within Rheumatoid Arthritis and Distinct Genetic Background of Rheumatoid Factor Levels from Anticyclic Citrullinated Peptide Antibodies (2018) (7)
- A Delphi Exercise to Identify Characteristic Features of Gout — Opinions from Patients and Physicians, the First Stage in Developing New Classification Criteria (2013) (7)
- Association of EMCN with Susceptibility to Rheumatoid Arthritis in a Japanese Population (2011) (7)
- Incidence of comprehensive hospitalization due to infection, cardiovascular disease, fractures, and malignancies in patients with rheumatoid arthritis (2017) (7)
- Effects of Denosumab in Japanese Patients With Rheumatoid Arthritis Treated With Conventional Antirheumatic Drugs: 36-month Extension of a Phase III Study (2021) (7)
- Methylthioadenosine (MeSAdo) phosphorylase deficiency in malignancy. (1988) (7)
- Identification of a compound heterozygote for adenine phosphoribosyltransferase deficiency (APRT*J/APRT*Q0) leading to 2,8-dihydroxyadenine urolithiasis (1990) (7)
- Rebamipide, an Amino Acid Analog of 2(1H)-Quinolinone, Inhibits the Formation of Human Osteoclasts (2016) (7)
- Ratio of Circulating IFNγ + “Th17 Cells” in Memory Th Cells Is Inversely Correlated with the Titer of Anti-CCP Antibodies in Early-Onset Rheumatoid Arthritis Patients Based on Flow Cytometry Methods of the Human Immunology Project (2016) (7)
- ITGAV polymorphism and disease susceptibility in a Japanese rheumatoid arthritis population (2007) (7)
- [Maintenance therapy for rheumatoid arthritis after remission following successful treatment using biologics]. (2007) (7)
- Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis (2017) (7)
- Therapeutic Effects of Alendronate on Bone Erosion and Atrophy in a Patient with Rheumatoid Arthritis and Hepatitis C Virus Infection (2008) (7)
- Lack of association between IL-15 genetic variants and progression of joint destruction in Japanese patients with rheumatoid arthritis (2013) (7)
- Successful treatment for sympathetic storms in a patient with neuro-Behçet’s disease (2009) (7)
- Association between serum vitamin D level and history of falls in elderly Japanese patients with rheumatoid arthritis (2016) (7)
- A merged presentation of clinical and radiographic data using probability plots in a clinical trial, the JESMR study (2012) (7)
- Evaluation of the severity of hypoxanthine-guanine phosphoribosyltransferase deficiency using viable T cells. (1985) (7)
- Updated version of Japanese Childhood Health Assessment Questionnaire (CHAQ) (2020) (7)
- FRI0278 The First Early Rheumatoid Arthritis, Certolizumab Pegol, Multicenter, Double-Blind, Randomized, Parallel-Group Study: C-Opera, in Patients Fulfilling the 2010 Acr/Eular Classification Criteria, Demonstrates Inhibition of Joint Damage Progression (2014) (6)
- A phase 2 study of E6011, an anti-Fractalkine monoclonal antibody, in patients with rheumatoid arthritis inadequately responding to biological disease-modifying antirheumatic drugs (2021) (6)
- Effectiveness of tacrolimus in comparison with methotrexate or biologics in propensity score-matched patients with rheumatoid arthritis (2016) (6)
- [Basic calcium phosphate crystal deposition disease]. (2003) (6)
- Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach (2015) (6)
- Efficacy and Safety of E6011, an Anti‐Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double‐Blind, Placebo‐Controlled Phase II Study (2020) (6)
- Erythematosus plaques with macrophage infiltration as an initial manifestation of macrophage activation syndrome in a patient with systemic lupus erythematosus (2014) (6)
- Prevalence of gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database (2020) (6)
- Successful delivery in a patient with clinically amyopathic dermatomyositis during pregnancy despite first-trimester acute exacerbation of interstitial lung disease (2017) (6)
- Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies. (2021) (6)
- Clinical efficacy, radiographic, and safety results of golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior therapy with disease-modifying antirheumatic drugs: Final results of the GO-MONO trial through week 120 (2018) (6)
- Serum MMP-3 in rheumatoid arthritis (2004) (6)
- Two young-adult female cases of dermatomyositis with antibodies for transcriptional intermediary factor 1-γ. (2012) (6)
- Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept (2012) (6)
- Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one (2017) (6)
- SAT0257 Clinical and Radiographic Effects after 52-Week of Adding Tocilizumab or Switching to Tocilizumab in RA Patients with Inadequate Response to Methotrexate: Results from A Prospective Randomized Controlled Study (Surprise Study) (2014) (6)
- Factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis: Results from the Institute of Rheumatology Rheumatoid Arthritis cohort study (2020) (5)
- Vitamin D deficiency is a risk factor for new fractures in Japanese postmenopausal women with rheumatoid arthritis: results from the IORRA cohort study (2021) (5)
- Survey of attitudes of non-pediatric rheumatologists among councilors of the Japan College of Rheumatology regarding transitional care (2017) (5)
- Integrating patients’ perceptions into clinical practice guidelines for the management of rheumatoid arthritis in Japan (2017) (5)
- Pneumatosis Intestinalis Associated with Juvenile Dermatomyositis (2016) (5)
- Subject Index, Vol. 35, 1985 (1985) (5)
- Hypersensitivity reaction against influenza vaccine in a patient with rheumatoid arthritis after the initiation of etanercept injections (2006) (5)
- Age and female gender associated with periodontal disease in Japanese patients with rheumatoid arthritis: Results from self-reported questionnaires from the IORRA cohort study (2020) (5)
- Clinical Manifestations and Myositis-Specific Autoantibodies Associated with Physical Dysfunction after Treatment in Polymyositis and Dermatomyositis: An Observational Study of Physical Dysfunction with Myositis in Japan (2016) (5)
- Prevention of joint destruction in patients with high disease activity or high C-reactive protein levels: Post hoc analysis of the GO-FORTH study (2016) (5)
- A novel peptide from TCTA protein inhibits proliferation of fibroblast-like synoviocytes of rheumatoid arthritis patients (2014) (5)
- Factors associated with decreasing serum 25(OH)D among Japanese patients with rheumatoid arthritis: Results from the IORRA cohort study (2018) (5)
- The increasing disease duration of patients at the time of orthopaedic surgery for rheumatoid arthritis (2012) (5)
- Genetic differences between type 1 diabetes with and without other autoimmune diseases (2018) (4)
- [Pseudogout--calcium pyrophosphate dihydrate crystal deposition disease]. (2003) (4)
- Three-year safety and two-year effectiveness of etanercept in patients with rheumatoid arthritis in Japan: Results of long-term postmarketing surveillance (2018) (4)
- Clinical Characteristics and Cytokine Profiles of Organizing Pneumonia in Patients with Rheumatoid Arthritis Treated with or without Biologics (2016) (4)
- Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan (2015) (4)
- Functional Analysis of Human Sodium-Phosphate Transporter 4 (NPT4/SLC17A3) Polymorphisms. (2011) (4)
- Assessment of the effectiveness of golimumab 50-mg and 100-mg regimens in patients with rheumatoid arthritis in daily practice (2015) (4)
- Factors associated with frailty in Japanese patients with rheumatoid arthritis: results from the Institute of Rheumatology Rheumatoid Arthritis cohort study (2021) (4)
- Identification of commonly recognized epitopes on a rare autoantigen: poly(ADP-ribose) polymerase. (1994) (4)
- Trend of patient characteristics and its impact on the response to adalimumab in patients with rheumatoid arthritis: post hoc time-course analysis of an all-case PMS in Japan (2015) (4)
- Neurodevelopmental disorders associated with juvenile fibromyalgia (2018) (4)
- Effect of hypouricemic agents on serum carbohydrate-deficient transferrin in gouty patients. (1994) (4)
- Identification of Two Novel Mutations in Adenine Phosphoribosyltransferase Gene in Patients with 2,8‐Dihydroxyadenine Urolithiasis (2004) (4)
- Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases (2022) (4)
- Clinicobiochemical analysis of four cases of xanthine oxidase deficiency. (1984) (4)
- Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment (2019) (4)
- Molecular Characterization of a Deletion in the HPRT1 Gene in a Patient with Lesch–Nyhan Syndrome (2011) (3)
- Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study) (2016) (3)
- Quantitative analysis with advanced compensated polarized light microscopy on wavelength dependence of linear birefringence of single crystals causing arthritis (2014) (3)
- Efficacy and safety of sirukumab in Japanese patients with moderate to severe rheumatoid arthritis inadequately controlled by disease modifying anti-rheumatic drugs: Subgroup analysis of a phase 3 study (2018) (3)
- 2-Chloroadenosine is phosphorylated and increases the production of hypoxanthine in human cells. (1986) (3)
- Systematic review and meta-analysis of biosimilar for the treatment of rheumatoid arthritis informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis. (2021) (3)
- [Serum markers of synovitis and bone metabolism in rheumatoid arthritis]. (2009) (3)
- Characterization of the Human Autoantibody Response to Poly(ADP-Ribose) Polymerase (1989) (3)
- Systemic lupus erythematosus associated with RASopathy (2017) (3)
- FRI0177 52-week results of clinical, radiographic and pharmacokinetic assessments: Golimumab, a human anti-TNF monoclonal antibody, administered subcutaneously every four weeks in patients with active rheumatoid arthritis despite methotrexate therapy (2013) (3)
- AB0468 Improved physical function, pain, and health related quality of life with certolizumab pegol in japanese rheumatoid arthritis patients with an inadequate response to methotrexate: Results from the jrapid study (2013) (3)
- A case of SLE-associated protein-losing gastroenteropathy accompanied by high serum levels of TGF-α and VEGF (2014) (3)
- Systematic review for the treatment of older rheumatoid arthritis patients informing the 2020 update of the Japan college of rheumatology clinical practice guidelines for the management of rheumatoid arthritis. (2021) (3)
- Trends in Risks of Malignancies in Japanese Patients with Rheumatoid Arthritis: Analyses from a 14-year Observation of the IORRA Cohort. (2022) (3)
- Efficacy and safety of tacrolimus in patients with rheumatoid arthritis – A systematic review and meta-analysis (2020) (3)
- Olokizumab Treatment of both Western and Asian Patients with Rheumatoid Arthritis who have Failed Anti-Tnf Treatment Results in Sustained Improvements in Patient-Reported Outcomes (2016) (3)
- Molecular cloning of poly adp ribosepolymerase using human autoantibodies (1987) (3)
- Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study (2020) (3)
- The minimally important difference for the Japanese version of the health assessment questionnaire in patients with rheumatoid arthritis in daily practice (2017) (3)
- SAT0481 Early Detection and Treatment for Borderline Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis in Japan (2015) (3)
- OP0223 EFFICACY AND SAFETY OF E6011, AN ANTI-FRACTALKINE MONOCLONAL ANTIBODY, IN MTX-IR PATIENTS WITH RHEUMATOID ARTHRITIS (2019) (3)
- SAT0186 Effects of denosumab, a subcutaneous rankl inhibitor, on the progression of structural damage in japanese patients with rheumatoid arthritis treated with csdmards: results from the 12-month double blind phase 3, desirable study (2017) (3)
- Genetic landscape of interactive effects of HLA-DRB1 alleles on susceptibility to ACPA(+) rheumatoid arthritis and ACPA levels in Japanese population (2017) (3)
- Real-world safety and efficacy of CT-P13, an infliximab biosimilar, in Japanese rheumatoid arthritis patients naïve to or switched from biologics (2021) (3)
- Microanalysis of Pathological Crystals and Urinary Calculi (1998) (3)
- Diagnostic Rate of Autoinflammatory Diseases Evaluated by Fever Patterns in Pediatric- and Adult-Onset Patients (2018) (3)
- AB0469 Improved physical function, pain, and health related quality of life with certolizumab pegol in japanese rheumatoid arthritis patients without methotrexate co-administration: Results from the hikari study (2013) (3)
- FRI0176 Golimumab, a human anti-TNF monoclonal antibody, administered subcutaneously every four weeks as monotherapy in patients with active rheumatoid arthritis despite dmard therapy: 52-week results of clinical, radiographic and pharmacokinetic assessments (2013) (3)
- Rapid Progressive Cerebral Atrophy in Systemic Lupus Erythematosus (2011) (3)
- Antiphospholipid Antibodies in Patients with Cutaneous Polyarteritis Nodosa and Livedo Vasculopathy (2013) (3)
- Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two (2017) (3)
- Efficacy and safety of sirukumab in Japanese patients with active rheumatoid arthritis who were refractory or intolerant to anti-tumor necrosis factor therapy: Subgroup analysis of a randomized, double-blind, multicenter, phase 3 study (SIRROUND-T) (2019) (3)
- Polypharmacy, declined walking speed, bent back, and disability associated with a history of falls in Japanese patients with rheumatoid arthritis: Results from the IORRA cohort study (2020) (3)
- [Revised version of Guideline for the Management of Hyperuricemia and Gout]. (2008) (3)
- Urate-lowering therapy for CKD patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the FEATHER Study (2022) (3)
- [Usefulness of serum matrix metalloproteinase-3(MMP-3) level in the diagnosis of rheumatoid arthritis]. (2002) (3)
- Childhood‐Onset Anti‐Ku Antibody‐Positive Generalized Morphea with Polymyositis: A Japanese Case Study (2015) (3)
- Bone erosion of the sternocostal joint in a patient with Behcet's disease. (2009) (2)
- THU0190 Better Clinical Responses Seen Early with the Loading Dose of Certolizumab Pegol are Maintained until One Year (2014) (2)
- Postmarketing Surveillance of Tocilizumab for Rheumatoid Arthritis In Japan-Full Analysis Report of 7,901 Patients. (2011) (2)
- Risk of herpes zoster in patients with rheumatoid arthritis in the biologics era from 2011 to 2015 and its association with methotrexate, biologics, and corticosteroids. (2021) (2)
- The origin of APRT*J. The most common disease-related mutation of APRT gene among Japanese goes back to a prehistoric era. (1998) (2)
- Significant joint-destructive association of HLA-DRB1*04:05 independent of DAS28 in rheumatoid arthritis (2018) (2)
- Intervention of somatic mutational events in vivo by a germline defect at the adenine phosphoribosyltransferase locus (1997) (2)
- Clinical images: Dramatic amelioration of pneumatosis cystoides intestinalis in systemic sclerosis. (2010) (2)
- Changes in Treatment Adherence and Behaviour During the COVID-19 Pandemic in Japanese Patients With Rheumatoid Arthritis: Results from Cross-Sectional Study in the IORRA Cohort (2022) (2)
- The evaluation of gene polymorphisms associated with autoinflammatory syndrome in patients with palindromic rheumatism complicated by intermittent hydrarthrosis (2020) (2)
- Progressive destructive bronchiolectasis followed by appearance of multiple pulmonary cystic lesions mimicking honeycombing in a patient with rheumatoid arthritis (2018) (2)
- A Case of Human Leukocyte Antigen (HLA) B27-Positive Intestinal Behçet’s Disease with Crohn’s Disease-Like Anal Fistulas (2014) (2)
- FRI0205 Golimumab administered subcutaneously every four weeks in patients with active rheumatoid arthritis despite methotrexate therapy: long-term clinical, radiographic and safety results, including evaluation of remission using the new acr/eular criteria (2013) (2)
- Pharmacodynamics of TMX-67 (TEI-6720), a novel xanthien dehydrogenase/oxidase inhibitor, in man (1997) (2)
- Title: Post-Marketing Surveillance of the Safety Profile of Infliximab in 5,000 Japanese Patients with Rheumatoid Arthritis (2007) (2)
- Risperidone in the treatment of corticosteroid-induced mood disorders, manic/mixed episodes, in systemic lupus erythematosus: a case series. (2012) (2)
- AB0620 Evaluation of Usefullness of Klebs Von Den Lungen-6 as A Biomarker of Interstitial Lung Disease with Polymyositis and Dermatomyositis Including That in The Short Time Course after Treatment (2016) (2)
- Erratum: Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity (Modern Rheumatology DOI: 10.1007/s10165-011-0586-5) (2012) (2)
- Characterization of poly(ADP-ribose) polymerase with human autoantibodies. (1989) (2)
- Persistence of maternal antibody and its effect on the antibody production in young mice. (1972) (2)
- Common altered characteristics of mutant enzymes from patients with Japanese type APRT deficiencies. (1986) (2)
- THU0092 The advantage of early intervention by tocilizumab for rheumatoid arthritis - full analysis of all-case postmarketing surveillance in 7,901 patients in japan (2013) (2)
- Regulation of S-Adenosylmethionine and Methylthioadenosine Metabolism in Methylthioadenosine Phosphorylase Deficient Malignant Cells (1986) (2)
- Selection of treatment regimens based on shared decision-making in patients with rheumatoid arthritis on remission in the FREE-J study (2022) (2)
- [HDL-cholesterol in patients with gout (author's transl)]. (1981) (2)
- SAT0126 A PHASE 2 STUDY OF E6011, AN ANTI-FRACTALKINE MONOCLONAL ANTIBODY, IN PATIENTS WITH RHEUMATOID ARTHRITIS INADEQUATELY RESPONDING TO BIOLOGICS (2019) (2)
- A simple screening test to assess risk of falls in Japanese patients with rheumatoid arthritis: Results from the IORRA cohort study (2020) (2)
- SAT0173 Baseline Parameters Identified in Early, Methotrexate-Naïve Rheumatoid Arthritis Patients with Better Outcomes with Certolizumab Pegol+Methotrexate Compared to Placebo+Methotrexate: Post-Hoc Analyses of C-OPERA, A Randomized, Controlled, Phase 3 Study (2015) (2)
- Pharmacogenetics of disease-modifying anti-rheumatic drugs. (2004) (2)
- Guillain-Barré syndrome accompanied by central nervous system lupus in a patient with juvenile rheumatoid arthritis (2001) (2)
- AB0291D PREDICTORS OF NEW BONE EROSION IN RHEUMATOID ARTHRITIS PATIENTS RECEIVING CSDMARDS: ANALYSIS OF DATA FROM THE DRIVE AND DESIRABLE STUDIES (2019) (2)
- FRI0117 Chronological changes in achieving j-haq remission in patients with early-stage rheumatoid arthritis in the iorra cohort (2017) (2)
- The occurrence of Japanese cedar pollinosis with rheumatoid arthritis. (2007) (2)
- Effectiveness and Safety of Subcutaneous Abatacept in Biologic-Naïve RA Patients at Week 52: A Japanese Multicenter Investigational Study (ORIGAMI Study) (2021) (2)
- Recent trend in the onset age of gouty arthritis in Japan (2004) (2)
- PMS55 EURO QOL (EQ-5D) BASED QOL (QUALITY OF LIFE) IN 5,023 JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS (RA) PATIENTS IN AN OBSERVATIONAL COHORT IORRA (2008) (1)
- Response to: 'Denosumab, cortical bone and bone erosion in rheumatoid arthritis' by Rossini et al. (2016) (1)
- Neuropsychiatric systemic lupus erythematosus: pathophysiology and the future of treatment (2013) (1)
- Retrospective analysis of liver toxicity due to anti-hvperuricemic drugs in Japan (2001) (1)
- Long-term Safety and Efficacy of E6011, an Anti-fractalkine Monoclonal Antibody, in Patients with Rheumatoid Arthritis Inadequately Responding to Methotrexate. (2023) (1)
- FRI0197 Golimumab monotherapy in patients with active rheumatoid arthritis despite dmard therapy: week 104 results of clinical, radiographic and safety assessments including evaluation of remission using the new acr/eular criteria (2013) (1)
- Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in Active Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study (2020) (1)
- Basic (PS01–PS58) (2012) (1)
- Technetium-99m Albumin Scintigraphy in Protein-Losing Gastroenteropathy With Systemic Lupus Erythematosus: Typical Diagnostic Pattern of Radiotracer Leakage and Chronological Improvement by Treatment. (2017) (1)
- A first evidence for an asymptomatic germline missense mutation in the hypoxanthine phosphoribosyltransferase (HPRT) gene in humans (1997) (1)
- AB0416 A COMPARATIVE STUDY TO ASSESS THE EFFICACY, SAFETY, AND IMMUNOGENICITY OF YLB113 AND ETANERCEPT REFERENCE PRODUCT FOR THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (2019) (1)
- PMS23 Analysis of Indirect Costs for Care of Rheumatoid Arthritis Patients Using Large Cohort Database, Iorra, in Japan (2011) (1)
- Susceptibility to Mouse Hepatitis Virus of Mice from Infected and Non-infected Breeding Colonies (1975) (1)
- The prevalence of purine metabolic disorders in Japan. (1986) (1)
- Tuberculosis-immune reconstitution inflammatory syndrome associated with juvenile enthesitis-related arthritis under treatment of adalimumab (2018) (1)
- FRI0436 CCPA Reverses the Fibrotic Phenotype of Dermal Fibroblasts in Systemic Sclerosis (2015) (1)
- [Effects of alcohol on urate metabolism]. (1997) (1)
- Experimental immunology Tumor necrosis factor-α and matrix metalloproteinase-3 production in rheumatoid arthritis synovial tissue is inhibited by blocking gap junction communication (2012) (1)
- Efficacy of Adalimumab in a Girl with Refractory Intestinal Behcet's Disease (2015) (1)
- Factors associated with successful discontinuation of certolizumab pegol in early rheumatoid arthritis (2020) (1)
- PReS-FINAL-2108: Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan (2013) (1)
- Rheumatoid arthritis and angiogenesis. (2003) (1)
- Capillary abnormalities observed by nailfold video-capillaroscopy in Japanese patients with systemic sclerosis (2018) (1)
- FRI0201 Immunogenicity of certolizumab pegol without concomitant methotrexate and clinical response in rheumatoid arthritis patients: post-hoc analysis of the hikari study (2013) (1)
- AB0121 Cyclic Phosphatidic Acid (CPA) Suppresses Expression of Cartilage Degrading Enzymes Such as MMP-3 and MMP-13, Also Increaces HAS-2 Expression in Inflammatory Rheumatoid Synovial Fibroblasts Induced by IL-1 Beta and/or TNF Alfa (2015) (1)
- AB0435 Effects of Prior Use of BIOLOGICS on the Safety and Effectiveness of Abatacept Administered with or without Methotrexate in Japanese Patients with Rheumatoid Arthritis: Sub-Analysis of the Abatacept All-Cases Post-Marketing Surveillance (2014) (1)
- [Immunological and serological tests for diagnosis of rheumatoid arthritis: MMP-3]. (2005) (1)
- Non-increased risk of thrombosis by steroid pulse therapy in patients with lupus nephritis from the Japanese health insurance database. (2020) (1)
- THU0342 Pregnancy Outcome in Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Study of 134 Pregnancies (2016) (1)
- THE PREVALENCE OF PURINE METABOLIC DISORDERS IN JAPAN: 143 (1985) (1)
- Response to ‘Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study’ (2014) (1)
- 277 Usefulness of soluble pd-1 in patients with systemic lupus erythematosus (2017) (1)
- Cross-sectional analysis of NSAID-related gastrointestinal injury in patients with RA (2002) (1)
- Generation and molecular characterisation of monoclonal IgG4 rheumatoid factor from a patient with rheumatoid arthritis (1997) (1)
- [Adenosine deaminase activity in childhood acute leukemia]. (1982) (1)
- A case of psoriatic arthritis, with joint involvement preceding skin involvement, successfully treated with adalimumab (80 mg every other week) (2019) (1)
- Effect of Adalimumab on Refractory Arthritis in Juvenile Idiopathic Inflammatory Myopathy with Anti-MDA5 Autoantibody (2018) (1)
- [A case of Sjögren syndrome suspected, rheumatoid arthritis and Behcet's disease complicated with cochlear nerve and trigeminal nerve disorders]. (2012) (1)
- Long-term Evaluation of E6011, an Anti-Fractalkine Monoclonal Antibody, in Patients with Rheumatoid Arthritis Inadequately Responding to Biological Disease-modifying Antirheumatic Drugs. (2023) (1)
- SAT0182 Relationship Between HLA-A Or -B LOCI and Behcet’S Disease in Japan. B51 is Related to Pathogenesis and A26 is Related to Ocular Lesions (2013) (1)
- [Rheumatic diseases and sex differences]. (2015) (1)
- THU0333 2-CARBA CYCLIC PHOSPHATIDIC ACID (2CCPA) SUPPRESSES PROFIBROTIC ACTIVITY IN SYSTEMIC SCLEROSIS SKIN FIBROBLASTS AND BLEOMYCIN-INDUCED SKIN FIBROSIS IN MICE (2019) (1)
- Design characteristics of the Corrona Japan rheumatoid arthritis registry (2018) (1)
- Prevalence of polymorphisms of the genes responsible for auto-inflammatory diseases among 202 patients with recurrent fever in a rheumatology institute in Japan (2014) (1)
- Hemophagocyctic lymphohistiocytosis developed in a Japanese boy with Chédiak-Higashi syndrome. (2013) (1)
- JAPANESE PATIENTS WITH PARTIAL APRT DEFICIENCIES ACCOMPANIED WITH 2,8-DIHYDROXYADENINE LITHIASIS SYNTHESIZE MUTANT APRT WITH ALTERED KINETIC PROPERTIES WHICH DOES NOT FUNCTION IN VIABLE CELLS: 98 (1985) (1)
- Microanalysis of pathological crystals and urinary calculi. (1997) (1)
- Management of End-stage Renal Disease Associated with Systemic Rheumatic Diseases (2019) (1)
- Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility in Japanese rheumatoid arthritis patients (2013) (1)
- Tonsillectomy to Effectively Treat a Patient with Behçet's Disease. (2016) (1)
- Selective inhibition of cytotoxic T lymphocyte proliferation by mizoribine (bredinin), an adenosine analog. (1989) (1)
- Erratum to: Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity (2012) (0)
- AB0294 Long-term comprehensive disease control with certolizumab pegol regardless of concomitant dmards: results from the japanese cohort (2013) (0)
- Divergent effects ofmethotrexate on theclonal growth ofT andBlymphocytes andsynovial adherent cells frompatients withrheumatoid arthritis (1996) (0)
- [Rheumatoid arthritis and neovascularization]. (2002) (0)
- Clinical images: Solitary extranodal malignant lymphoma of the forearm in rheumatoid arthritis. (2011) (0)
- Systematic review for the treatment of older rheumatoid arthritis patients informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis. (2021) (0)
- [Action mechanism of androgens]. (1984) (0)
- Influence of Concomitant Methotrexate use on the Clinical Effectiveness, Retention, and Safety of Abatacept in Biologic-Naïve Patients with Rheumatoid Arthritis: Post-hoc Subgroup Analysis of ORIGAMI Study. (2022) (0)
- OP0187 INCIDENCE OF MALIGNANCY IN JAPANESE PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE JAPANESE IORRA PATIENT REGISTRY (2021) (0)
- 2-carba-cyclic Phosphatidic Acid Suppresses Expression of Cartilage Degrading Enzymes such as MMP-3, MMP-13 and ADAMTS-4 in Inflammatory Synovial Fibroblasts and Articular Chondrocytes Induced by IL-1 Beta and/or TNF Alfa (2017) (0)
- Diagnosis ofHeterozygous States forAdenine Phosphoribosyltransferase Deficiency Basedon Detection ofIn VivoSomaticMutantsinBloodT Cells: Application toScreening ofHeterozygotes (1991) (0)
- SAT0211 Effectiveness and Safety of Tocilizumab in Biologics Naïve RA Patients – PMS for Investigating Success in Achieving Clinical and Functional Remission and Sustaining Efficacy with Tocilizumab in Biologics-Naïve RA Patients (First Bio) Study (2015) (0)
- peripheral blood T cell culture using T cell growth factor A new method for the detection of Lesch-Nyhan heterozygotes by (2011) (0)
- Impact of Concomitant Chronic Kidney Disease on Hospitalized Infections and Remission in Patients with Rheumatoid Arthritis: Results from the IORRA Cohort. (2021) (0)
- Achievements from a large cohort study of rheumatoid arthritis (2017) (0)
- AB0571 A Cross-Sectional Study of Health-Related Quality of Life Assessed by The SF-36 and The EQ-5D-5L in Patients with Anca-Associated Vasculitis (2016) (0)
- Systematic review and meta-analysis of biosimilar for the treatment of rheumatoid arthritis informing the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis. (2021) (0)
- Bone Analysis of T-Cell Leukaemia Translocation-Associated Gene (TCTA)Transgenic Mice and Conditional Knockout Mice: Possibility that TCTA ProteinExpressed on Osteoclasts Plays a Role as a Novel Coupling Factor In Vivo (2017) (0)
- [Expression and genetic alteration of HGPRT gene: basic and clinical aspects]. (1985) (0)
- Time-averaged disease activity fits better joint destruction in rheumatoid arthritis (2017) (0)
- [The mechanism of gonadotropin secretion in the male (author's transl)]. (1980) (0)
- SAT0173 Effects of denosumab, a subcutaneous rankl inhibitor, on the progression of structural damage in japanese patients with rheumatoid arthritis treated with csdmards: result from the long-term treatment of phase 3, desirable study (2018) (0)
- A case of enteropathic arthritis successfully treated with methotrexate. (2016) (0)
- [Clinical effect of water-soluble guaiazulene in inflammatory lesions of the oral mucosa by "keeping technic" (author's transl)]. (1974) (0)
- [A questionnaire-based survey on the Internet concerning optimal timing for knee surgery in a patient with rheumatoid arthritis]. (2001) (0)
- A first evidence of an asymptomatic germline missense base substitution in the hypoxanthine phosphoribosyltransferase (HPRT) gene in humans. (1998) (0)
- Heterogeneity of the toxic mechanisms of methylthioadenosine in methylthioadenosine phosphorylase deficient murine lymphoma cells. (1989) (0)
- 180 MODULATION OF DIPHTHAMIDE SYNTHESIS BY METHYLTHIOADENOSINE (1988) (0)
- THU0086 FACTORS ASSOCIATED WITH TREATMENT RESPONSE IN PATIENTS WITH ELDERLY-ONSET RHEUMATOID ARTHRITIS: 3-YEAR OBSERVATION USING THE IORRA COHORT. (2020) (0)
- Diagnosis of Lesch-Nyhan heterozygotes by peripheral blood. (1986) (0)
- Adherence to denosumab for the treatment of osteoporosis in Japanese patients with rheumatoid arthritis: Results from the IORRA cohort study (2020) (0)
- Comparison of the characteristics of rheumatoid arthritis patients in clinical trials and clinical practice (2011) (0)
- FRI0282 Post-Treatment Short-Term Changes in Needle Electromyography among Patients with Polymyositis and Dermatomyositis and Their Clinical Usefulness: A Retrospective Study (2016) (0)
- Thematic stream: inflammatory arthritis (PP01–PP31)PP01. Autoinflammatory Synovitis in Familial Mediterranean Fever is Characterized by Numerous Neutrophils Lacking Myeloperoxidase and Lysozyme, Macrophages, Mast Cells and B Cells, Up-Regulation of Galectin-1, P65 (REL A)/NF-ΚB and Inos, but not COX (2011) (0)
- Positive Correlation of RANK Expression on Human Monocytes with Age: RANK Expressed on Human Monocytes may play a Role in Senile Osteoporosis (2017) (0)
- Comparison of surface differentiation antigens between HGPRT-positive and negative T-cells from two Lesch-Nyhan heterozygotes. (1986) (0)
- OP0095 INFLUENCE OF PERIODONTITIS ON DISEASE ACTIVITY, PHYSICAL FUNCTION, AND SAFETY IN PATIENTS WITH RHEUMATOID ARTHRITIS: A OBSERVATIONAL STUDY USING THE IORRA COHORT (2019) (0)
- Efficacy of tocilizumab for rheumatoid arthritis patients in daily practice in Japan-message from REACTION study (2010) (0)
- AB0065 2-CARBA-cyclic phosphatidic acid suppresses expression of cartilage degrading enzymes such as MMP-13 in inflammatory synovial fibroblasts and articular chondrocytes induced by IL-1 BETA and/or TNF ALFA (2017) (0)
- [Programs for Continuing Medical Education: A session; 6. Management of rheumatoid arthritis--Perspective from internists]. (2016) (0)
- Lower injection‐site reactions and long‐term safety, immunogenicity, and efficacy of etanercept biosimilar YLB113: Results from a post‐hoc analysis of a double‐blind, randomized, phase III comparative study and its open‐label extension in patients with rheumatoid arthritis (2022) (0)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM) (2007) (0)
- Characteristics of infants born to mothers with autoimmune disorders (2014) (0)
- AB0154 The il12rb2 gene is a novel candidate susceptible to systemic sclerosis in the japanese population (2013) (0)
- Quantification of PAP39 and PRS1 mRNA by competitive PCR (1997) (0)
- 9. Progress of Treatment of Rheumatoid Arthritis (2009) (0)
- FRI0259 A Retrospective Study: Predictive Factors for Insufficient Improvement of Muscle Weakness after Treatment among Patients with Polymyositis and Dermatomyositis (2016) (0)
- DIAGNOSIS OF LESCH-NYHAN HETEROZYGOTES USING PERIPHERAL BLOOD: 97 (1985) (0)
- OP0221 HAVE 5-YEAR SURVIVAL RATE AND MORTALITY CHANGED IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS IN THE PAST TWENTY YEARS?-RESULTS FROM THE IORRA COHORT (2020) (0)
- [ Bone and cartilage destruction in RA and its intervention. Disease-modifying antirheumatic drugs]. (2012) (0)
- Association of Autoantigenic Epitope and Catalytic Site on Poly (ADP-Ribose) Polymerase (1989) (0)
- [Physiopathological interpretation and progress in diagnosis and treatment. 2) Gout and pseudogout]. (2000) (0)
- [112th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: Diagnosis and Management of Hyperuricemia and Gout]. (2015) (0)
- [Drug therapy for idiopathic hyperuricemia--introduction, dose, and side effects]. (2003) (0)
- Pregnancy in Patients with SLE (2015) (0)
- THU0330 Validiity of Protein-To-Creatinine Ratio in An Untimed Urine Specimen and Estimated Glomerular Filtration Rate as Measures of Proteinuria and Renal Function in Patients with Lupus Nephritis (2016) (0)
- rheumatoid arthritis promoter polymorphism with FCRL 3 of the Supportive evidence for a genetic association (2005) (0)
- FRI0473 Mpo-anca positivity is related to interstitial lung disease in systemic sclerosis (2018) (0)
- A case of agranulocytosis which was effectively treated with G-CSF (1992) (0)
- SAT0120 Characteristics Associated with Better Effectiveness and Safety in Rheumatoid Arthritis Patients Treated with Intravenous Tocilizumab: Results from Full Analysis of All-Patient Postmarketing Surveillance in Japan (2013) (0)
- Association between hypoxanthine concentration in synovial fluid and joint destruction in patients with rheumatoid arthritis (1998) (0)
- Colonoscopy was useful for the diagnosis and the guidance of treatment escalation/de-escalation in a refractory case of lupus colitis (2018) (0)
- Effectiveness, safety, and methotrexate dose-tapering pattern over two years of treatment with adalimumab and ≥12 mg/week methotrexate for early rheumatoid arthritis: Results of the HAWK postmarketing surveillance study in Japan (2020) (0)
- [Physiopathology and treatment of gout and hyperuricemia]. (1999) (0)
- SAT0071 ANALYSIS OF CHRONOLOGICAL CHANGES IN JAPANESE VERSION OF HEALTH ASSESSMENT QUESTIONNAIRE SCORE AND FACTORS ASSOCIATED WITH J-HAQ REMISSION AT 5 YEARS AFTER DISEASE ONSET IN PATIENTS WITH RHEUMATOID ARTHRITIS USING THE IORRA COHORT (2019) (0)
- Functional Analysis of Human Sodium-Phosphate Transporter 4 ( NPT 4 / SLC 17 A 3 ) Polymorphisms (2011) (0)
- Successful discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in real-world settings (2021) (0)
- FRI0115 TRAJECTORIES OF THE EQ-5D SCORE AMONG A LARGE COHORT OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH BIOLOGICAL DMARDS USING THE IORRA COHORT (2019) (0)
- 10 of Concomitant Disease-modifying Antirheumatic Drugs Combination Therapy in Japanese Patients with Rheumatoid Arthritis : Effect Safety and Effectiveness of 6 Months ' Etanercept Monotherapy and Yoshinaga and Michio Suzukawa (2013) (0)
- D-penicillamine prevents processes of B cell activation but does not inhibit ongoing immunoglobulin production by synovial tissue cells from patients with rheumatoid arthritis (1993) (0)
- Unregulated prescribing of anti- tumour necrosis factor agents does not mean inappropriate prescribing (2010) (0)
- SAT0667 Presepsin and procalcitonin are of diagnostic value for bacterial infection in patients with connective tissue diseases (2017) (0)
- [Leflunomide for therapy of rheumatoid arthritis]. (2005) (0)
- A germline partial deletion of adenine phosphoribosyltransferase gene presumably related to the suppression of loss of heterozygosity in somatic cells (1997) (0)
- PMS67 CONJOINT ANALYSIS OF REDUCTION OF CO-PAYMENT RATE OF NATIONAL HEALTH INSURANCE SYSTEM IN JAPAN (2010) (0)
- THU0157 Clinical Outcomes at Week 104 and Analysis of Associated Baseline Factors after An Initial 1 Year of Certolizumab Pegol and MTX Treatment in MTX-Naïve Patients with Early RA: Results from The Second Year of The C-Opera Study (2016) (0)
- Search for the mechanisms of high incidence of APRT deficiency among Japanese. (1994) (0)
- Dose-Response Effects Of Denosumab, a Novel Subcutaneous RANKL Inhibitor, On The Progression Of Bone Erosion In Japanese Patients With Rheumatoid Arthritis Treated With Methotrexate : Results Of Phase II DRIVE Study-A Twelve Month Placebo Controlled, Randomized, Double Blind Study (2013) (0)
- Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis (2017) (0)
- Pharmacogenomics in the treatment of rheumatoid arthritis: clinical implication and perspective. (2006) (0)
- FRI0099 PREDICTIVE FACTORS FOR REMISSION ACHIEVEMENT BY TOCILIZUMAB MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER INADEQUATE RESPONSE TO METHOTREXATE: A POST HOC ANALYSIS OF THE SURPRISE STUDY (2019) (0)
- [How to select and use urate lowering agents for hyperuricemia]. (1996) (0)
- SAT0185 Characteristics of Cytokine Profiles and Prognositc Factors in Interstitial Lung Disease with Polymyositis/Dermatomyositis (2013) (0)
- Rheumatoid Factor Is Associated with the Distribution of Hand Joint Destruction in a Dose-Dependent Manner (2015) (0)
- Association between patient-reported outcomes and impairments in work and activity in patients with rheumatoid arthritis in clinical remission: a retrospective analysis using the IORRA database. (2022) (0)
- [Prospective cohort studies of incident fractures in patients with rheumatoid arthritis]. (2007) (0)
- THU0144 DESCRIPTIVE ANALYSIS OF PREGNANCY, DELIVERY, AND LACTATION IN PATIENTS WITH RHEUMATOID ARTHRITIS FROM THE IORRA COHORT. (2020) (0)
- AB0668 A Pilot Study of the Eicosapentaenoic Acid/Arachidonic Acid (EPA/AA) Ratio Level of Japanese Patients with Behçet's Disease (2015) (0)
- OP0111 Tocilizumab discontinuation after attaining remission in patients with rheumatoid arthritis who were treated with tocilizumab alone or in combination with methotrexate: results from a prospective, randomised, controlled study (THE SECOND YEAR OF THE SURPRISE STUDY) (2018) (0)
- Instructions for use Title Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients withrheumatoid arthritis (2017) (0)
- 17 PROFOUND TOXICITY OF DEOXYADENOSINE (dAdo) AND 2-CHLORODEOXYADENOSINE (CdA) TOWARD HUMAN MONOCYTES IN VITRO AND IN VIVO (1988) (0)
- THU0405 Prevalence of and Factors Associated with Vitamin D Deficiency in 4,793 Japanese Patients with Rheumatoid Arthritis (2013) (0)
- Novel development of collagen disease rheumatism medical care. II. Treatment. 2. Practice of articular rheumatism early treatment. (2005) (0)
- Urate-lowering therapy for gout and asymptomatic hyperuricemia in the pediatric population: a cross-sectional study of a Japanese health insurance database (2021) (0)
- Utilization of 2'-deoxynad for ADP-ribose transfer reactions. (1989) (0)
- Intra-articular Administration of Cyclic Phosphatidic Acid ( cPA ) Suppresses Pain , Swelling , and Articular Cartilage Degeneration in Knee Joints with Rabbit Experimental Osteoarthritis (2014) (0)
- AB0230 Centromere Pattern Exhibits A Specific Distribution of Titers among Anti-Nuclear Antibodies (ANAS) and Characterizes A Distinct Subset in Rheumatoid Arthritis (2016) (0)
- The origin of the most common mutation of adenine phosphoribosyltransferase deficiency among Japanese goes back to a prehistoric era (1997) (0)
- Subjective Symptoms Contributing to the Quality of Life of Rheumatoid Arthritis Patients with Clinical Remission from the IORRA Database. (2022) (0)
- Japan Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in (2009) (0)
- Serum level of matrix metalloproteinase-3 as a useful marker for predicting the progression of joint destruction in patients with early rheumatoid arthritis (2001) (0)
- Infliximab; Indication and the safety profile in RA patients in Japan (2004) (0)
- Juvenile idiopathic arthritis with no complaints of joint pain in early childhood (2018) (0)
- [A case of carpal tunnel syndrome caused by tophaceous gout (author's transl)]. (1982) (0)
- AB0486 Effect of Baseline Disease Duration on Development of Clinical Remission in the RA Patients Receiving Tocilizumab – Data from PMS with Tocilizumab in Biologics-Naïve RA Patients (First Bio) Study (2015) (0)
- Influence of Inflammation on Lipid Metabolism in the Patients with Rheumatoid Arthritis (2004) (0)
- 284 Clinical usefulness of quantitative measurement of anti-m-type phospholipase a2 receptor antibodies in patients with membranous nephropathy and comparisons of three quantitative methods (2017) (0)
- Biological Insights From Genetics Of Rheumatoid Arthritis Contribute To Drug Discovery (2013) (0)
- Socioeconomic impact of treatment with biological disease-modifying antirheumatic drugs in Japanese patients with rheumatoid arthritis. (2023) (0)
- Factors affecting treatment discontinuation in patients with gout (2013) (0)
- SAT0166 An Analysis of Laboratory Results from 2 Randomized, Double-Blind Studies of Sirukumab in Patients with Active Rheumatoid Arthritis Refractory To Disease-Modifying Anti-Rheumatic Drug Treatment (2016) (0)
- Differences in patients' population and efficacy/effectiveness of biologic disease-modifying antirheumatic drugs between randomized controlled trials and real-world settings in patients with rheumatoid arthritis - using the IORRA cohort. (2021) (0)
- [Clinical epidemiology of rheumatoid arthritis--activities of J-ARAMIS]. (2005) (0)
- SAT0460 Association of the Hypoxia-Inducible Factor 1A (Hif1Alpha) Gene Polymorphism in Japanese Systemic Sclerosis (SSC) with the Pulmonary Arterial Hypertension (PAH) (2015) (0)
- PReS-FINAL-2125: A Japanese girl with childhood-onset anti-Ku antibody positive generalized morphea-myositis overlap syndrome (2013) (0)
- HIKARI trial of certolizumab pegol 557 (2018) (0)
- Tocilizumab Review of its Use in the Management of (2009) (0)
- The First, Multicenter, Double-Blind, Randomized, Parallel-Group Study of Certolizumab Pegol in Early Rheumatoid Arthritis Demonstrates Inhibition of Joint Damage Progression. (2014) (0)
- Prevalence of polymorphisms of the genes responsible for auto-inflammatory diseases among 236 patients with recurrent fever in a rheumatology institute in Japan (2015) (0)
- Unincreased mortality of patients with early rheumatoid arthritis compared to the general population in the past 17 years: Analyses from the IORRA cohort. (2023) (0)
- [Progress in the study of allergy and collagen disease in the last 100 years: Gout]. (2002) (0)
- SAT0615 THE DIFFERENT EFFECTS OF CIGARETTE SMOKING ON ANTI-CITRULLINATED CYCLIC PROTEIN ANTIBODY AND RHEUMATOID FACTOR FORMATION IN RELATION TO SHARED EPITOPE ALLELES IN JAPANESE RA PATIENTS (2019) (0)
- FRI0691 DISCREPANCY BETWEEN THE EFFICACY OF BIOLOGICAL DMARDS BASED ON RANDOMIZED CONTROLLED TRIALS AND THE EFFICACY OF BIOLOGICAL DMARDS IN REAL-WORLD SETTINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A STUDY USING THE IORRA COHORT (2019) (0)
- FRI0210 Real-world hawk study: long-term safety and effectiveness of adalimumab with higher-dose methotrexate in japanese patients with early rheumatoid arthritis (2017) (0)
- Four cases of HLA-A*26(+)/B*51(−) intestinal Behçet’s disease without abdominal symptoms (2018) (0)
- AB0257 ASSESSMENT OF PHYSICAL DYSFUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO PLANNED PREGNANCY FROM THE IORRA COHORT. (2020) (0)
- FRI0512 Risk of opportunistic infections in patients with antineutrophil cytoplasmic antibody-associated vasculitis using japanese health insurance database (2018) (0)
- [A new method for the determination of xanthine oxidase activity by high-performance liquid chromatography with electrochemical detection]. (1992) (0)
- 14. Crystal-related Arthropathies (2010) (0)
- Chance Finding of Proteinuria Leads to the Diagnosis of ANCA Associated Vasculitis (2009) (0)
- THE ASSOCIATION BETWEEN HYPERTENSION AND THE SEVERITY OF GOUTY ARTHRITIS IN TAIWAN (2009) (0)
- Characterization of the cloned rheumatoid synovial cells in long-term culture. (1987) (0)
- AB0554 RISK OF CORONARY ARTERY DISEASE AND STROKE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS USING JAPANESE HEALTH INSURANCE DATABASE (2019) (0)
- Disease state and treatment of gout and hyperuricemia. (1999) (0)
- [Rheumatoid arthritis: progress in diagnosis and treatment. Topics: IV. Treatment: 1. Treatment strategies, 1) guidelines for the management of rheumatoid arthritis]. (2012) (0)
- Instructions for use Title Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis : results from alarge Japanese postmarketing surveillance study (2019) (0)
- THU0199 Week 12 Clinical Response to Certolizumab Pegol Predicts Long-Term Outcomes Regardless of Concomitant Medications and Baseline Disease Characteristics in Japanese Patients with Active Rheumatoid Arthritis (2013) (0)
- THU0459 Clinical Characteristics in Rheumatoid Arthritis (RA) - Type of Patients with Adult-Onset Still’s Disease (2013) (0)
- PMS51 MAJOR DETERMINANTS OF EUROQOL (EQ-5D) IN PATIENTS WITH RHEUMATOID ARTHRITIS BASED ON A LARGE JAPANESE COHORT IORRA (2008) (0)
- FRI0678 PREVALENCE, PATIENT CHARACTERISTICS, AND TREATMENT OF GOUT AND ASYMPTOMATIC HYPERURICEMIA IN JAPAN: CROSS-SECTIONAL STUDY OF A HEALTH INSURANCE CLAIMS DATABASE (2019) (0)
- Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data (2022) (0)
- [108th Scientific Meeting of the Japanese Society of Internal medicine: invited lecture: 5. IORRA, a large cohort study for rheumatoid arthritis in Japan]. (2011) (0)
- PMS27 ANALYSIS OF DIRECT MEDICAL AND NON-MEDICAL COSTS FOR CARE OF RHEUMATOID ARTHRITIS PATIENTS USING LARGE COHORT DATABASE, IORRA (2010) (0)
- Determination of urinary bucillamine and its metabolite in patients with rheumatoid arthritis. Relationship between the metabolism of bucillamine and its clinical effectiveness. (1993) (0)
- [Rheumatoid arthritis]. (2010) (0)
- FRI0285 Initial Adalimumab plus Methotrexate Treatment Prevents Joint Destruction Irrespective of Treatment Duration in Japanese Patients with Early Rheumatoid Arthritis: Post-Hoc Analysis of HOPEFUL 1 and 2 Studies (2014) (0)
- [Diagnosis and treatment of rheumatoid arthritis:toward the best practice. How to use the guideline in the management of rheumatoid arthritis.] (2018) (0)
- 181 CHARACTERIZATION OF POLY(ADP-RIBOSE) POLYMERASE WITH HUMAN AUTOANTIBODIES (1988) (0)
- Evaluation of serum carbohydrate-deficient transferrin as a marker of heavy drinking in gouty patients (1995) (0)
- AB1025 HARMONIZING JAPANESE VERSION OF THE CHILDHOOD HEALTH ASSESSMENT QUESTIONNAIRE (CHAQ) WITH CHAQ (2019) (0)
- Painless lumps in the proximal interphalangeal joints in tricho‐rhino‐phalangeal syndrome type 1 (2015) (0)
- Effect of the change in serum uric acid levels on mortality: A prospective cohort study (1998) (0)
- Non-Drug and Surgical Treatment Algorithm and Recommendations for the 2020 Update of the Japan College of Rheumatology Clinical Practice Guidelines for the Management of Rheumatoid Arthritis - Secondary Publication. (2022) (0)
- THU0166 Comparison of the risk of comorbidities between patients with rheumatoid arthritis and diabetes mellitus using japanese health insurance database (2017) (0)
- Genome-wide Association Study of Idiopathic Osteonecrosis of the Femoral Head (2017) (0)
- AB1295 DISCREPANCIES BETWEEN THE RHEUMATOID ARTHRITIS PATIENT POPULATION IN RANDOMIZED CONTROLLED TRIALS OF BIOLOGICS AND THAT IN REAL-WORLD SETTINGS: A STUDY USING THE IORRA COHORT (2019) (0)
- COMPARISON OF SURFACE DIFFERENTIATION ANTIGENS BETWEEN SEPARATED HGPRT-POSITIVE AND NEGATIVE T-CELL POPULATIONS FROM TWO LESCH-NYHAN HETEROZYGOTES: 233 (1985) (0)
- Major depressive disorder in patients with rheumatoid arthritis Eri SatoKatsuji NishimuraAyako NakajimaHiroshi Okamoto • Mikiko ShinozakiEisuke InoueAtsuo TaniguchiShigeki Momohara • (2013) (0)
- [Antirheumatic agents for treatment of rheumatoid arthritis]. (2008) (0)
- FRI0238 RISK OF THROMBOSIS IN PATIENTS RECEIVING STEROID PULSE THERAPY IN LUPUS NEPHRITISUSING JAPANESE HEALTH INSURANCE DATABASE (2019) (0)
- Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part three (2017) (0)
- Consistent Inhibition of Joint Destruction By Denosumab in Important Subgroups of Japanese Patients with Rheumatoid Arthritis : Pooled Analysis of Phase 2 and 3 Studies (2017) (0)
- Kremezin as an alternative strategy to reduce the temporal increase of serum uric acids (2005) (0)
- Musculoskeletal ultrasonography in patients with gout: A single-institute experience at the Institute of Rheumatology, Tokyo Women's Medical University. (2011) (0)
- 2-COROADENOSINE IS PHOSPHORYLATED AND INCREASES THE PRODUCTION OF HYPOXANTHINE IN HUMAN CELLLS: 234 (1985) (0)
- FRI0146 Incidence Rate and The Risk of Herpes Zoster in Patients with Rheumatoid Arthritis Using Japanese Health Insurance Database (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Hisashi Yamanaka?
Hisashi Yamanaka is affiliated with the following schools:
